Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects

PURPOSE: This study was performed to compare the pharmacokinetics of two fixed-dose combination (FDC) formulations of teneligliptin combined with modified-release metformin in healthy Korean subjects under fasting and fed conditions. PATIENTS AND METHODS: The study was a single-center, open-label, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Goak, In Sun, Lee, Jin A, Jeong, Min Ho, Moon, Seol Ju, Kim, Min Gul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805719/
https://www.ncbi.nlm.nih.gov/pubmed/36597442
http://dx.doi.org/10.2147/DDDT.S393675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805719/
https://www.ncbi.nlm.nih.gov/pubmed/36597442
http://dx.doi.org/10.2147/DDDT.S393675

Ejemplares similares